Andrew Barton v. United States District Court For The Central District Of California

Good Law
410 F.3d 1104·2005 U.S. App. LEXIS 10701
United States Court of Appeals for the Ninth CircuitJune 9, 200505-71086California3,882 words

Opinion

Opinion

410 F.3d 1104 Andrew BARTON; Kenneth Borenstein; Gerri Marin; Trishia Medema; and James Meythaler, Petitioners, v. UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA, Respondent, Smithkline Beecham Corporation, dba GlaxoSmithKline, A Pennsylvania Corporation, Real Party in Interest. No. 05-71086. United States Court of Appeals, Ninth Circuit. Argued and Submitted May 12, 2005. Filed June 9, 2005. Robert M. Brava-Partain and Karen Barth Menzies, Baum Hedlund, A Professional Corp., Los Angeles, CA, for the petitioners. James D. Miller, King & Spaulding LLP, Washington, D.C., and Vernon I. Zvoleff, Drinker Biddle & Reath LLP, San Francisco, CA, for the real party in interest. Petition for Writ of Mandamus to the United States District Court for the Central District of California; Mariana R. Pfaelzer, District Judge, Presiding. D.C. No. CV-01-07937-MRP. Before KLEINFELD, HAWKINS, and GRABER, Circuit Judges. KLEINFELD, Circuit Judge. 1 We grant a writ of mandamus to prevent disclosure of communications by prospective clients to their lawyers. 2 Facts. 3 Plaintiffs sued SmithKline Beecham Corporation, which does business as GlaxoSmithKline. They claim injury…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.